Metabolic syndrome in rural Bangladesh: Comparison of newly proposed IDF, modified ATP III and WHO criteria and their agreements

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 1, Issue 4, 2007, Pages 251-257

  Rahim, M A ^a   Azad Khan, A K ^b   Sayeed, M A ^b   Akhtar, Banu ^d   Nahar, Q ^c   Ali, S M K ^d   Hussain, A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

Adult Treatment Panel III; Bangladesh; International Diabetes Federation; Metabolic syndrome; Rural population; World Health Organization

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BANGLADESH; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE CLASSIFICATION; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RURAL POPULATION; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION;

EID: 35548951869     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2007.09.006     Document Type: Article

References (29)

1. Eckel R.H., Grunduy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
2. Reaven G.M. Banting lecture role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
3. Paul Z., and Alberti G. The metabolic syndrome: perhaps an etiologic mystery but far from myth-where does the International Diabetes Federation Stand?. Medscape Diabet Endocr 7 2 (2005). http://www.medscape.com/ posted10/11/2005. www.medscape.com
4. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary disease using risk factor categories. Circulation 97 (1998) 1837-1847
5. Alberti K.G.M.M., Zimmet P.Z., and for the WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complication. Part 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
6. Balkau B., Charles M.A., and European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO consultation. Diabet Med 16 (1999) 442-443
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive Summary of the third report. JAMA 2001;285:2486-97.
8. Alexander C.M., Loansman P.B., and Haffner S.M. Prevalence of metabolic syndrome and coronary heart disease using NCEP and WHO criteria. Diabetes 51 Suppl. 2 (2002) 883 [Abstracts]
9. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
10. Alberti K.G.M.M., Zimmet P., and Shaw J. Metabolic syndrome-a new world wide definition. A consensus Statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
11. WHO Expert Consultation. Appropriate body mass index for Asian population and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
12. Hussain A., Rahim M.A., Azad Khan A.K., and Ali S.M.K. Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh. Diabet Med 22 (2005) 931-937
13. Ramachandran A., Snehalatha C., Kapur A., Vijay V., Mohan V., Das A.K., et al. High prevalence of diabetes and impaired glucose tolerance in India: national urban diabetes survey. Diabetologia 44 (2001) 1094-1101
14. Rahim M.A., Hussain A., Azad Khan A.K., Sayeed M.A., Ali S.M.K., and Vaaler S. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study. Diabetes Res Clin Pract 77 (2007) 300-305
15. Vaccaro O., and Riccardi G. Changing the definition of impaired fasting glucose. Diabetes Care 28 (2005) 1786-1788
16. Western Pacific Regional Office of the World Health Organization. The International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communication Australia, http://www.obesittyasiapacific.com; 2000.
17. Grundy S.M., Brewer H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
18. Ramachandran A., Snehalatha C., Satyavani K., Sivasankari S., and Vijay V. Metabolic syndrome in urban Asian Indian adults-a population studies using modified ATP III criteria. Diabetes Res Clin Pract 60 (2003) 199-204
19. Rajeev G., Prakash C., Deedwania A., Gupta S.R., Raja B.P., and Kunal K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 97 (2004) 257-261
20. Ko G.T.C., Cockram C.S., Chow C.C., Yeung V.T.F., Chan W.B., So W.Y., et al. High prevalence of metabolic syndrome in Hong Kong Chinese-comparison of three diagnostic criteria. Diabetes Res Clin Pract 69 (2005) 160-168
21. Thomas G.N., Ho S.Y., Janus E.D., Lam K.S.L., Hedley A.J., Lam T.H., et al. The Hong Kong Cardiovasculer Risk Factor Prevalence Study Steering Committee. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 67 (2005) 251-257
22. Earl S.F., Wayne H.G., and Ali H.M. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
23. Ford E.S., and Giles W.H. A comparison of prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26 (2003) 575-581
24. Earl S.F. Prevalence of metabolic syndrome defined by IDF among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
25. Ang L.W., Ma S., Cutter J., Chew S.K., Tanc C.E., and Tai E.S. The metabolic syndrome in Chinese, Malays, and Asian Indians, factor analysis of data from 1998 Singapore National Health Survey. Diabetes Res Clin Pract 67 (2005) 53-62
26. Resnick H.E. On behalf of the strong heart study investigators metabolic syndrome in American Indians. Diabetes Care 25 (2002) 1246-1247
27. Whyte J.L., L'Italien G.J., and Chen R.S. The prevalence of the metabolic syndrome and its associated CHD risk in United States. Diabetes 51 Suppl. 2 (2002) 979 [Abstracts]
28. Meiges J.B., Haffner S.M., Williams K., Natahan D.M., D'Agostino R.B., and Wilson P.W.F. Prevalence and the characteristic of the metabolic syndrome by NCEP-ATP III criteria in the San Antonio and Framingham offspring subjects. Diabetes 52 (2003) 2160-2167
29. Cham J.C., Cheung J.C., Stehoiwer C.D., Emies J.J., Tong P.C., Ko G.T., et al. The central roles of obesity-associated dislipidaemia. Endothelial activation and cytokines in the metabolic syndrome-an analysis between structural equation modeling. Int J Obes Relat Metab Disord 26 (2002) 994-1008